Jaguar Health, Inc. (JAGX) stock
JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.39−0.03 (-7.14%)
Close on Nov 16, 2026Market cap $2.02MP/E –Yield –
Jaguar Health total assets
Total assets on the balance sheet at the end of each period.
Jaguar Health's total assets was $34.19M at Jun 30, 2026. For fiscal 2025 it was $38.32M, down 28.3% from the year before. Over ten years it grew 11.9% a year on average. The highest annual figure on record is $53.43M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.32M | -28.3% |
| FY2024 | Dec 31, 2024 | $53.43M | +5.2% |
| FY2023 | Dec 31, 2023 | $50.76M | +7.0% |
| FY2022 | Dec 31, 2022 | $47.45M | -10.9% |
| FY2021 | Dec 31, 2021 | $53.27M | +24.3% |
| FY2020 | Dec 31, 2020 | $42.84M | +17.7% |
| FY2019 | Dec 31, 2019 | $36.41M | -11.3% |
| FY2018 | Dec 31, 2018 | $41.04M | -5.9% |
| FY2017 | Dec 31, 2017 | $43.63M | +1124.5% |
| FY2016 | Dec 31, 2016 | $3.56M | -71.3% |
| FY2015 | Dec 31, 2015 | $12.41M | +180.7% |
| FY2014 | Dec 31, 2014 | $4.42M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $34.19M | -29.2% |
| Q1 FY2026 | Mar 31, 2026 | $37.43M | -27.3% |
| Q4 FY2025 | Dec 31, 2025 | $38.32M | -28.3% |
| Q3 FY2025 | Sep 30, 2025 | $49.47M | -15.4% |
| Q2 FY2025 | Jun 30, 2025 | $48.27M | -21.5% |
| Q1 FY2025 | Mar 31, 2025 | $51.46M | -7.1% |
| Q4 FY2024 | Dec 31, 2024 | $53.43M | +5.2% |
| Q3 FY2024 | Sep 30, 2024 | $58.47M | +28.8% |
| Q2 FY2024 | Jun 30, 2024 | $61.46M | +17.8% |
| Q1 FY2024 | Mar 31, 2024 | $55.39M | -2.7% |
| Q4 FY2023 | Dec 31, 2023 | $50.76M | +7.0% |
| Q3 FY2023 | Sep 30, 2023 | $45.38M | -11.5% |
| Q2 FY2023 | Jun 30, 2023 | $52.17M | +4.6% |
| Q1 FY2023 | Mar 31, 2023 | $56.93M | +7.6% |
| Q4 FY2022 | Dec 31, 2022 | $47.45M | -10.9% |
| Q3 FY2022 | Sep 30, 2022 | $51.29M | -13.4% |
| Q2 FY2022 | Jun 30, 2022 | $49.89M | -28.3% |
| Q1 FY2022 | Mar 31, 2022 | $52.91M | -23.0% |
| Q4 FY2021 | Dec 31, 2021 | $53.27M | +24.3% |
| Q3 FY2021 | Sep 30, 2021 | $59.26M | +63.5% |
| Q2 FY2021 | Jun 30, 2021 | $69.54M | +85.0% |
| Q1 FY2021 | Mar 31, 2021 | $68.71M | +106.5% |
| Q4 FY2020 | Dec 31, 2020 | $42.84M | +17.7% |
| Q3 FY2020 | Sep 30, 2020 | $36.23M | +1.7% |
| Q2 FY2020 | Jun 30, 2020 | $37.58M | +4.2% |
| Q1 FY2020 | Mar 31, 2020 | $33.28M | -18.2% |
| Q4 FY2019 | Dec 31, 2019 | $36.41M | -11.3% |
| Q3 FY2019 | Sep 30, 2019 | $35.63M | -22.8% |
| Q2 FY2019 | Jun 30, 2019 | $36.07M | -21.9% |
| Q1 FY2019 | Mar 31, 2019 | $40.66M | -6.8% |
| Q4 FY2018 | Dec 31, 2018 | $41.04M | -31.6% |
| Q3 FY2018 | Sep 30, 2018 | $46.12M | +833.9% |
| Q2 FY2018 | Jun 30, 2018 | $46.16M | +1191.2% |
| Q4 FY2017 | Dec 31, 2017 | $43.63M | +1124.5% |
| Q3 FY2017 | Sep 30, 2017 | $59.99M | +1075.9% |
| Q2 FY2017 | Jun 30, 2017 | $4.94M | -31.4% |
| Q1 FY2017 | Mar 31, 2017 | $3.57M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.56M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.10M | – |
| Q2 FY2016 | Jun 30, 2016 | $7.20M | – |
See a number that looks wrong?